Five-year overall survival of pembrolizumab in advanced non-small cell lung cancer: another step from care to cure?

Ann Transl Med. 2019 Sep;7(Suppl 6):S212. doi: 10.21037/atm.2019.08.91.

Authors

Paolo Bironzo¹, Francesco Passiglia¹, Silvia Novello¹

Affiliation

¹ Department of Oncology, University of Torino, AOU S. Luigi Gonzaga, Orbassano, Italy.

No abstract available

Publication types

Editorial
Comment